APA (7th ed.) Citation

Uemura, M., Fujimura, Y., Ko, S., Matsumoto, M., Nakajima, Y., & Fukui, H. Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis. Wiley.

Chicago Style (17th ed.) Citation

Uemura, Masahito, Yoshihiro Fujimura, Saiho Ko, Masanori Matsumoto, Yoshiyuki Nakajima, and Hiroshi Fukui. Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis. Wiley.

MLA (9th ed.) Citation

Uemura, Masahito, et al. Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis. Wiley.